Home » FDA Issues Emergency Use Authorization for Centogene’s COVID-19 Assay
FDA Issues Emergency Use Authorization for Centogene’s COVID-19 Assay
The FDA has issued an Emergency Use Authorization to Centogene for the company’s new SARS-CoV-2 polymerase chain reaction (PCR) test for detection of the COVID-19 coronavirus.
The reverse-transcription PCR assay uses upper respiratory tract samples from potential or confirmed COVID-19 patients.
The test is intended for use by qualified laboratory personnel in the company’s high-complexity laboratories in Germany.
Upcoming Events
-
02May
-
07May
-
14May
-
23May
-
30May